Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Org Lett ; 16(1): 302-5, 2014 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-24299213

RESUMO

Three convergent routes to thiophenes are described, hinging on the radical addition of α-xanthyl ketones to ethyl vinyl sulfide or to vinyl pivalate. The latter route ultimately proved to be the most versatile and efficient (61-94%).

2.
J Med Chem ; 56(5): 2074-86, 2013 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-23421599

RESUMO

A series of bimetallic [(NHC)PtX2]2(diamine) complexes have been prepared as a new chemotype for potential anticancer agents. These complexes display an uncommon set of structural features as far as they combine two bifunctional, trans-configured platinum centers. They display cytotoxic activities in the micromolar range on many cancerous cell lines and do not cross-react with cisplatin in A2780/DDP cell lines. They bind slowly to double-stranded DNAs, giving monoadducts as the major products. Pathways for cellular toxicity have been investigated for both mono- and bimetallic trans-(NHC)PtX2(amine) complexes. It has been highlighted that, unlike cisplatin, these complexes do not induce cell cycle arrest. They trigger apoptosis in A2780 cells by a pathway involving translocation of apoptosis-inducing factor and caspase 12 to the nucleus. Moreover, bimetallic complexes may induce necrosis.


Assuntos
Antineoplásicos/farmacologia , DNA/metabolismo , Compostos Organoplatínicos/farmacologia , Antineoplásicos/síntese química , Apoptose/efeitos dos fármacos , Fator de Indução de Apoptose/metabolismo , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Cisplatino/farmacologia , Fragmentação do DNA , Diaminas/síntese química , Diaminas/farmacologia , Humanos , Concentração Inibidora 50 , Compostos Organoplatínicos/síntese química
3.
Chem Soc Rev ; 41(14): 4884-908, 2012 Jul 21.
Artigo em Inglês | MEDLINE | ID: mdl-22674143

RESUMO

This review illustrates enantioselective transition-metal promoted skeletal rearrangements of polyunsaturated substrates possessing olefin, alkyne or allene functions. These processes are classified according to the number of carbon atoms involved in the cyclization, from (1C+1C) to (2C+2C+2C) or (2C+5C) cyclizations. Thus, for instance, (1C+1C) processes are typified notably by Alder-ene type reactions taking place mainly under palladium and rhodium catalysis, in the presence of chiral phosphorus ligands. Also, rhodium, platinum, and gold promoted insertions of unsaturated carbon-carbon bonds into C-H bonds belong to this class. For each class of reactions or substrate type the best ligand-metal pairs are highlighted. Unfortunately, unlike other transition metal promoted reactions, the mechanisms of chiral induction and stereochemical pathways have not been established so far in any of these reactions. In only a few instances, qualitative heuristic models have been tentatively proposed. Although the available stereochemical information is systematically given here, the paper focuses mainly on synthetic aspects of enantioselective cycloisomerizations.

4.
Org Lett ; 11(10): 2137-9, 2009 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-19374390

RESUMO

A new family of cyclometalated (N-heterocyclic carbene)-Pt(II) complexes bearing monodentate phosphines as ancillary ligands has been designed for use as precatalysts in 1,6-enyne cycloisomerization reactions. Highly enantioselective skeletal rearrangements of allylpropargyl-tosylamide derivatives have been developed by using (S)-Ph-Binepine as the chiral auxiliary. Enantiomeric excesses up to 97% have been obtained.


Assuntos
Alcinos/química , Compostos Heterocíclicos com 1 Anel/síntese química , Compostos Organometálicos/síntese química , Platina/química , Catálise , Ciclização , Compostos Heterocíclicos com 1 Anel/química , Compostos Organometálicos/química , Estereoisomerismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...